Alzheimer's Disease Trial, Recruiting (NCT07673770)

Alzheimer's Disease Trial, Recruiting NCT07673770 Sponsor: McMaster University Condition: Alzheimer's Disease

Printed from Voxsanity (voxsanity.com.au) — NCT07673770 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Alzheimers Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who have been diagnosed with Alzheimer's Disease or a related form of dementia by a doctor or clinician
People who are able to communicate verbally and have enough cognitive function to score above 10 on a standard memory and thinking test called the MMSE (confirm with trial site)
People who can understand instructions given in English
People who are 55 years of age or older

Who may not be able to join:

People who have a pacemaker, certain metal, electrical, or magnetic implants (titanium implants are generally not excluded), a known history of untreated or uncontrolled mental health conditions, current pregnancy, a history of seizures, or a diagnosis of epilepsy, as these may be safety concerns with the treatment method used in this trial (confirm with trial site)
People who are currently taking prescription medications known to increase the risk of seizures
People who have an allergy to rubbing alcohol, which is used to prepare the skin for a measurement procedure in this trial

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: (905) 525-9140

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07673770

Sponsor: McMaster University

Phase: Not Applicable

Status: Recruiting

Condition: Alzheimer's Disease

Trial contact: (905) 525-9140

More information: https://clinicaltrials.gov/study/NCT07673770

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who have been diagnosed with Alzheimer's Disease or a related form of dementia by a doctor or clinician
People who are able to communicate verbally and have enough cognitive function to score above 10 on a standard memory and thinking test called the MMSE (confirm with trial site)
People who can understand instructions given in English
People who are 55 years of age or older

Who may not be able to join:

People who have a pacemaker, certain metal, electrical, or magnetic implants (titanium implants are generally not excluded), a known history of untreated or uncontrolled mental health conditions, current pregnancy, a history of seizures, or a diagnosis of epilepsy, as these may be safety concerns with the treatment method used in this trial (confirm with trial site)
People who are currently taking prescription medications known to increase the risk of seizures
People who have an allergy to rubbing alcohol, which is used to prepare the skin for a measurement procedure in this trial

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

McMaster University

Registry

ClinicalTrials.gov

Start date

7 July 2026

Est. completion

1 April 2028

Where this trial is recruiting

🇨🇦 Canada

Primary endpoints

Forward digit span; Reverse digit span; Sentence span; Grocery list task; Montreal Cognitive Assessment (MoCA) score; Mini-Mental State Examination (MMSE) scores

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov